MedPath

T cell homeostasis after ATG induced lymphocytopenia in renal transplant patients; studied through in vivo 2H2O labeling

Completed
Conditions
low white blood cells
10047954
10018188
lymphocytopenia
10027665
Registration Number
NL-OMON35541
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
9
Inclusion Criteria

Renal transplantation patients treated with standard maintenance immunosuppressive therapy who were treated with ATG because of acute humoral graft rejection and renal transplantation patients treated with standard maintenance immunosuppressive therapy alone. Healthy volunteers, without relevant medical history.

Exclusion Criteria

Patients with intercurrent medical problems

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The amount of 2H2O incorporated into the DNA within the naïve CD4+ and CD8+ T<br /><br>cells will be measured. With special mathematical formulas the production rate<br /><br>and half-life of cells can be calculated. T cell homeostasis in the ATG treated<br /><br>patients, versus the standard immunosuppressive treated patients and versus the<br /><br>healthy volunteers will be analysed through comparing production rates and<br /><br>half-life of the naïve T cells. For that purpose we will use methods that have<br /><br>been described in the literature, and we will collaborate with these same<br /><br>investigators.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Production rates and half-life of the CD31+ CD4 naive T cells.</p><br>
© Copyright 2025. All Rights Reserved by MedPath